Abiomed, Inc. operates within the Surgical and medical instruments sector. In addition to historical fundamental analyses, the complete report available to purchase compares Abiomed with three other companies in this sector in UNITED STATES : Cantel Medical Corp. (2020 sales of $1.02 billion ), Accuray Inc ($382.93 million of which 56% was Service), and Haemonetics Corporation ($988.48 million of which 47% was Plasma).

Sales Analysis. During the year ended March of 2020, sales at Abiomed were $840.88 million. This is an increase of 9.3% versus 2019, when the company's sales were $769.43 million. This was the fifth consecutive year of sales increases at Abiomed (and since 2015, sales have increased a total of 265%). Sales of Service and Other Revenue saw an increase that was more than double the company's growth rate: sales were up 22.8% in 2020, from $27.73 million to $34.06 million.